SENDhelp
Many myths about ADHD persist in public awareness and even among some professionals. This guide addresses the most common ADHD myths with accurate, evidence-based information to support better understanding.
Despite ADHD being one of the most researched neurodevelopmental conditions, many myths and misconceptions about it persist in public awareness and even among some professionals. These myths can prevent people from seeking diagnosis, cause families to feel judged or blamed, lead to inadequate or inappropriate support and create barriers to treatment. Accurate information about ADHD, grounded in current evidence and in the lived experience of people with ADHD, is essential for challenging these misconceptions.
SENDhelp places specialist SEN teachers, teaching assistants and support staff in schools and provisions across North London, Bedfordshire, Buckinghamshire and Hertfordshire. If your school needs staff experienced with ADHD, we can help.
ADHD is one of the most thoroughly researched neurodevelopmental conditions. It is recognised by the NHS, the World Health Organisation and all major psychiatric and psychological professional bodies. ADHD has identifiable neurobiological correlates including differences in dopamine and norepinephrine signalling and differences in the development of the prefrontal cortex and associated circuits. The evidence base for ADHD is as strong as for any other neurodevelopmental condition.
ADHD affects people of all genders. While ADHD is diagnosed more frequently in boys, this largely reflects differences in how ADHD presents rather than true differences in prevalence. Girls with ADHD more commonly have the predominantly inattentive presentation, less disruptive and therefore less likely to prompt referral. Growing recognition of how ADHD presents in girls and women has led to significantly increased rates of diagnosis in females in recent years.
ADHD continues into adulthood in approximately 60 to 70 percent of those diagnosed in childhood. The way ADHD presents changes over the lifespan: overt hyperactivity typically reduces, while inattention, disorganisation and emotional dysregulation may become more prominent challenges. Many adults with undiagnosed ADHD continue to experience significant difficulties with organisation, relationships, employment and mental health throughout their lives.
ADHD medication prescribed appropriately and monitored by a healthcare professional is safe and effective. Stimulant medications including methylphenidate are among the most studied medications in psychiatry. Properly prescribed ADHD medication is not associated with increased risk of addiction: research suggests it may actually reduce the risk of substance misuse by improving self-regulation. Common side effects including reduced appetite and sleep difficulties can usually be managed through dose adjustment.
ADHD is a neurodevelopmental condition with a strong genetic basis. It is not caused by parenting style, diet, sugar consumption, screen time or any other environmental factor that has been thoroughly researched. Sugar intake does not cause ADHD: controlled double-blind studies have repeatedly found no causal link. Poor parenting does not cause ADHD. Parents of children with ADHD should not feel responsible for the condition.
The ability to sustain attention in ADHD depends heavily on interest, novelty, challenge and urgency rather than on effort or importance. People with ADHD can appear to focus on activities they find genuinely engaging, which leads to the mistaken conclusion that they could focus on other tasks if they just tried harder. In reality, the ADHD brain regulates attention very differently from the neurotypical brain and this is not a matter of effort or willpower but of neurodevelopmental difference.
For related information see our articles on ADHD Explained and ADHD Diagnosis Process.
Yes. ADHD is a well-established neurodevelopmental condition with decades of research support, including neuroimaging evidence of brain differences, genetic studies confirming high heritability and evidence-based treatments with demonstrated effectiveness. It is recognised by the NHS, the World Health Organisation and all major psychiatric and psychological professional bodies.
No. Properly prescribed ADHD medication is not associated with increased risk of addiction. Research suggests that effectively treating ADHD may actually reduce the risk of substance misuse by improving self-regulation. Stimulant medications are controlled substances requiring special prescriptions, but this reflects their classification rather than a high risk of addiction when used as prescribed for ADHD.
No. ADHD is a neurodevelopmental condition with a strong genetic basis involving differences in how the brain regulates attention, impulse control and activity level. The difficulties people with ADHD experience are not the result of laziness, bad character or lack of effort. Many people with ADHD work significantly harder than their neurotypical peers to achieve the same outcomes and experience considerable frustration at their difficulties.
Visit our Understanding ADHD hub for more guides on signs, diagnosis, types, medication, executive function and co-occurring conditions.
The information in this article is provided for educational purposes only and is not intended as medical advice. If you have concerns about ADHD or any neurodevelopmental condition, speak to a qualified healthcare professional. SENDhelp Education Limited accepts no responsibility or liability for any loss or damage arising from reliance on this content. Any links to third-party websites are provided for convenience only and do not constitute endorsement of their content.
To stop receiving marketing emails or SMS’s from SENDhelp, kindly complete the form below. We strive to promptly remove your information, aiming to complete the process as soon as we receive your submission.